Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis
NCT ID: NCT04942769
Last Updated: 2021-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2019-12-20
2021-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Selenium Supplementation in Autoimmune Thyroiditis
NCT02013479
Selenium Supplementation in Youths With Autoimmune Thyroiditis
NCT02644707
Selenium Treatment in Autoimmune Thyroiditis (AIT)
NCT00271427
Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT
NCT02302768
Neuropsychologic and Immunological Evaluation in Treatment of Thyroid Diseases. Is Selenium Efficient?
NCT01247077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
selenium
selenium was administered to patients with autoimmune thyroiditis
Selenium
selenium 100ug ，take it orally twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Selenium
selenium 100ug ，take it orally twice daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of autoimmune thyroiditis, serum TPOAb and TGAB positive
* Thyroid function is normal, and no drugs affecting thyroid function such as Umetole and Serge have been used
Exclusion Criteria
* Hypothyroidism, hyperthyroidism
* Liver function impairment
* Renal function impairment
* Claustrophobia
* Mental disorders
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Chao Yang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guang Wang
Professor and Director, Department of Endocrinology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guang Wang
Role: PRINCIPAL_INVESTIGATOR
Beijing Chao Yang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-310
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.